Unusual 11 Midday Movers 01/31: (PRXL) (CTHR) (REE) (MSPD) Higher; (RSH) (PPO) (RTIX) Lower
Down)
RadioShack (NYSE: RSH) 29.5% LOWER; reports preliminary Q4 sales of $1.39 billion and EPS in the range of 11-13 cents. Street currently at $1.35 billion in sales and EPS of 37 cents. Suspending its buyback program. Sees FY12 net income down compared to FY11.
Polypore International (NYSE: PPO) 23.7% LOWER; shares are trading lower today on substantially higher volumes and news that one of its major competitors, LG Chemical, will be opening a separator plant by the second half of 2012.
Parexel International Corp (NASDAQ: PRXL) 19.4% HIGHER; reported Q2 EPS of $0.23, in-line with the analyst estimate of $0.23. Revenue for the quarter came in at $333.2 million versus the consensus estimate of $334.49 million. Sees Q3 2012 EPS of $0.30-$0.32, versus the consensus of $0.30. Sees Q3 2012 revenue of $350-$358 million, versus the consensus of $347.05 million. Sees FY2012 EPS of $1.09-$1.17, versus the consensus of $1.11. Sees FY2012 revenue of $1.360-$1.375 billion, versus the consensus of $1.36 billion
Charles & Colvard (Nasdaq: CTHR) 14.4% HIGHER; reported preliminary Q4 sales results which were 90 percent higher than the corresponding period of 2010 where sales were $3.5 million.
RTI Biologics, Inc. (NASDAQ: RTIX) 14.3% LOWER; reported Q4 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $42.9 million versus the consensus estimate of $41.24 million. Sees Q1 2012 EPS of $0.03, versus the consensus of $0.04, and sees Q1 2012 revenue of $41-$42 million, versus the consensus of $42.46 million. Sees FY2012 EPS of $0.15-$0.17, versus the consensus of $0.18, and sees FY2012 revenue of $174-$176 million, versus the consensus of $175.84 million.
Kona Grill Inc. (Nasdaq: KONA) 13.3% LOWER; reported it has named Berke Bakay president and Chief Executive Officer following the departure of Mike Nahkunst.
MannKind Corporation (Nasdaq: MNKD) 12.9% LOWER; announced that it intends to offer and sell, subject to market and other conditions, $50 million worth of units in an underwritten public offering, with each unit consisting of one share of MannKind’s common stock and a warrant to purchase 0.6 of a share of MannKind’s common stock. MannKind also intends to grant to the underwriters of the offering an option to purchase additional units to cover over-allotments, if any. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Rare Element Resources (NYSE: REE) 12.5% HIGHER; the WTO said China's limits on exports of minerals like coke, magnesium, and others artificially inflated prices and gave domestic Chinese firms an unfair competitive advantage. Click here for the full report.
National Bank of Greece (NYSE: NBG) 12.4% HIGHER; the stock is up more than 85 percent so far in 2012. Traders continue to buy the stock as a proxy Greece will successfully recover. The country is currently eying its second bailout.
Mindspeed Technologies, Inc. (NASDAQ: MSPD) 12.2% HIGHER; reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.9 million versus the consensus estimate of $33.32 million. Sees Q2 2012 revenue of $33.5-$35.5 million, versus the consensus of $33.4 million.
Array Biopharma, Inc. (NASDAQ: ARRY) 10.9% HIGHER; reported Q2 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $21.76 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Polypore International (NYSE: PPO) 23.7% LOWER; shares are trading lower today on substantially higher volumes and news that one of its major competitors, LG Chemical, will be opening a separator plant by the second half of 2012.
Parexel International Corp (NASDAQ: PRXL) 19.4% HIGHER; reported Q2 EPS of $0.23, in-line with the analyst estimate of $0.23. Revenue for the quarter came in at $333.2 million versus the consensus estimate of $334.49 million. Sees Q3 2012 EPS of $0.30-$0.32, versus the consensus of $0.30. Sees Q3 2012 revenue of $350-$358 million, versus the consensus of $347.05 million. Sees FY2012 EPS of $1.09-$1.17, versus the consensus of $1.11. Sees FY2012 revenue of $1.360-$1.375 billion, versus the consensus of $1.36 billion
Charles & Colvard (Nasdaq: CTHR) 14.4% HIGHER; reported preliminary Q4 sales results which were 90 percent higher than the corresponding period of 2010 where sales were $3.5 million.
RTI Biologics, Inc. (NASDAQ: RTIX) 14.3% LOWER; reported Q4 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $42.9 million versus the consensus estimate of $41.24 million. Sees Q1 2012 EPS of $0.03, versus the consensus of $0.04, and sees Q1 2012 revenue of $41-$42 million, versus the consensus of $42.46 million. Sees FY2012 EPS of $0.15-$0.17, versus the consensus of $0.18, and sees FY2012 revenue of $174-$176 million, versus the consensus of $175.84 million.
Kona Grill Inc. (Nasdaq: KONA) 13.3% LOWER; reported it has named Berke Bakay president and Chief Executive Officer following the departure of Mike Nahkunst.
MannKind Corporation (Nasdaq: MNKD) 12.9% LOWER; announced that it intends to offer and sell, subject to market and other conditions, $50 million worth of units in an underwritten public offering, with each unit consisting of one share of MannKind’s common stock and a warrant to purchase 0.6 of a share of MannKind’s common stock. MannKind also intends to grant to the underwriters of the offering an option to purchase additional units to cover over-allotments, if any. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Rare Element Resources (NYSE: REE) 12.5% HIGHER; the WTO said China's limits on exports of minerals like coke, magnesium, and others artificially inflated prices and gave domestic Chinese firms an unfair competitive advantage. Click here for the full report.
National Bank of Greece (NYSE: NBG) 12.4% HIGHER; the stock is up more than 85 percent so far in 2012. Traders continue to buy the stock as a proxy Greece will successfully recover. The country is currently eying its second bailout.
Mindspeed Technologies, Inc. (NASDAQ: MSPD) 12.2% HIGHER; reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.9 million versus the consensus estimate of $33.32 million. Sees Q2 2012 revenue of $33.5-$35.5 million, versus the consensus of $33.4 million.
Array Biopharma, Inc. (NASDAQ: ARRY) 10.9% HIGHER; reported Q2 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $21.76 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Notable 52-Week Highs and Lows of the Day 05/25: (LCC) (RPRX) High; (DCTH) (MXWL) (VIP) Low
- Morning Movers 05/24: (GENE) (GNOM) (P) Higher; (NTAP) (PCX) (TIF) Lower
- Notable Analyst Rating Changes 05/24: (PPG) (WPI) (DUK) Upgraded; (BHI) (HGSI) (COG) Downgraded
Create E-mail Alert Related Categories
Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
